Grove Biopharma, Inc. | $30,000,000 | (Apr 25, 2025)
Northwood | $30,000,000 | (Apr 25, 2025)
Steadily Insurance Company | $30,000,000 | (Apr 25, 2025)
1nhaler
United Kingdom
- Edinb
- 28/11/2023
- Unknown
- $2,527,000
We are making life-saving drugs more available to more people around the world.
The 1nhaler is a breath-activated, single dose, disposable dry powder inhaler that is the size of a credit card.
Our highly inventive, patented mechanism for drug delivery allows the 1nhaler to transform from its basic 2D flat shape into a 3D inhaler that can deliver a broad variety of inhalable drugs.
This low-cost device is made from cardboard and completely flat in storage. As a result, it is uniquely portable, distributable and recyclable. It will help to replace traditional inhalers that are estimated to account for 3% of the NHS carbon footprint.
For more information, please get in touch.
- Industry Medical Device
- Website N/A
- LinkedIn https://www.linkedin.com/company/1nhaler-ltd/about/
Related People
Lisa McMynCo Founder
United Kingdom -
N/A
Experienced business executive, product development expert and serial entrepreneur. Now focused on making life-saving drugs more available to more people with the 1nhaler - the smallest, simplest, most sustainable dry powder inhaler in the world.
Alternative Payments | $22,000,000 | (Apr 25, 2025)
Listen Labs | $27,000,000 | (Apr 25, 2025)
Lace | $14,000,000 | (Apr 25, 2025)
RISE® Robotics | $1,500,000 | (Apr 25, 2025)
Ravenna | $15,000,000 | (Apr 25, 2025)
ChEmpower Corporation | $18,700,000 | (Apr 25, 2025)
Theo | $20,000,000 | (Apr 25, 2025)
Isembard | $9,000,000 | (Apr 25, 2025)
Electra(US) | $186,000,000 | (Apr 25, 2025)